跳至主要内容
临床试验/CTRI/2023/01/048800
CTRI/2023/01/048800尚未招募未知

A Proof-of-Concept Study to Explore the Role of Neostigmine in Snake Bite in Tertiary Care Hospital in North India: A Double-Blind Randomized Placebo Controlled Trial

nil0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a)Aged 13 years and above
  • b)Neuroparalytic snakebite patients, with typical symptoms occurring within 24 hours
  • c)Neuroparalytic symptoms manifesting as: dyspnea, dysphonia, dysarthria, diplopia, dysphagia, ptosis, paralysis
  • d)Other signs of impending respiratory failure i.e. diminished or absent deep tendon reflexes and head lag
  • e)Additional features like stridor, ataxia; associated hypertension and tachycardia
  • f)Willing to sign voluntarily a statement of written informed consent/assent to participate in the study

排除标准

  • 未提供

研究者

发起方
nil

相似试验